06/20/2013

Pomerantz receives American Cancer Society grant

Recent research from the research group of Professor

Professor William Pomerantz and his researchers have been awarded an American Cancer Society Institutional Research Grant to support their research designing a class of peptide mimetic, which they term polarity switch peptides. Molecular design rules are being developed as a general approach for inhibiting transcription factor-protein interactions involved in acute myeloid leukemia. In-cell ¹⁹F nuclear magnetic resonance methods are also being investigated to quantitate cellular uptake of these compounds. This one-year award will cover research expenditures, starting July 1.